Tracie Oliver - 20 Jun 2022 Form 3 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Chief Commercial Officer
Signature
/s/Tracie Oliver
Issuer symbol
ARWR
Transactions as of
20 Jun 2022
Net transactions value
$0
Form type
3
Filing time
29 Jun 2022, 19:11:05 UTC
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARWR Common Stock 70,000 20 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 70,000 restricted stock units, which shares will vest over four years.